Biotricity, Inc.
BTCY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14 | $10 | $8 | $7 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $13 | $27 | $26 | $25 |
| Enterprise Value | $27 | $36 | $34 | $32 |
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | 0.3% | 4.6% | 2.3% | – |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 81.9% | 80.5% | 80.4% | 76.4% |
| EBITDA | $0 | $0 | -$1 | -$0 |
| % Margin | 9.6% | 8.6% | -23.7% | -2.4% |
| Net Income | -$1 | -$1 | -$2 | -$1 |
| % Margin | -17.8% | -17.3% | -52.3% | -34% |
| EPS Diluted | -0.026 | -0.029 | -0.088 | -0.054 |
| % Growth | 8.4% | 67.5% | -62.5% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |